These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31752186)

  • 1. An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares.
    Ghiggeri GM; D'Alessandro M; Bartolomeo D; Degl'Innocenti ML; Magnasco A; Lugani F; Prunotto M; Bruschi M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.
    González C; Garcia-Berrocal B; Herráez O; Navajo JA; González-Buitrago JM
    Clin Chem Lab Med; 2004 Mar; 42(3):266-72. PubMed ID: 15080558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-double stranded DNA, anti-histone, and anti-nucleosome IgG reactivities in children with systemic lupus erythematosus.
    Massa M; De Benedetti F; Pignatti P; Albani S; Di Fuccia G; Monestier M; Martini A
    Clin Exp Rheumatol; 1994; 12(2):219-25. PubMed ID: 8039294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-chromatin (anti-nucleosome) antibodies.
    Gómez-Puerta JA; Burlingame RW; Cervera R
    Lupus; 2006; 15(7):408-11. PubMed ID: 16898174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus.
    Chabre H; Amoura Z; Piette JC; Godeau P; Bach JF; Koutouzov S
    Arthritis Rheum; 1995 Oct; 38(10):1485-91. PubMed ID: 7575698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N; Villalta D; Giavarina D; Tozzoli R
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV).
    Ding Y; Zhou Y; Zhao J; Wu C; Zhang S; Jiang N; Qian J; Zhang L; Li J; Xu D; Leng X; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2024 Aug; 33(9):986-997. PubMed ID: 38853349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DNA antibodies and their relationships with anti-histone and anti-nucleosome specificities.
    Jacob L; Viard JP
    Eur J Med; 1992 Nov; 1(7):425-31. PubMed ID: 1341483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
    Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S
    Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.
    Schett G; Smole J; Zimmermann C; Hiesberger H; Hoefler E; Fournel S; Muller S; Rubin RL; Steiner G
    Lupus; 2002; 11(11):704-15. PubMed ID: 12475000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to nucleosomes and histone-DNA complexes.
    Monestier M
    Methods; 1997 Jan; 11(1):36-43. PubMed ID: 8990087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
    Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
    Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC; Kramers C; Berden JH
    Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.